JNK2 modulates the CD1d-dependent and -independent activation of iNKT cells

Jianyun Liu, Richard M. Gallo, Masood A. Khan, Abhirami K. Iyer, Ian M. Kratzke, Randy R. Brutkiewicz

Research output: Contribution to journalArticle

Abstract

Invariant natural killer T (iNKT) cells play critical roles in autoimmune, anti-tumor, and anti-microbial immune responses, and are activated by glycolipids presented by the MHC class I-like molecule, CD1d. How the activation of signaling pathways impacts antigen (Ag)-dependent iNKT cell activation is not well-known. In the current study, we found that the MAPK JNK2 not only negatively regulates CD1d-mediated Ag presentation in APCs, but also contributes to CD1d-independent iNKT cell activation. A deficiency in the JNK2 (but not JNK1) isoform enhanced Ag presentation by CD1d. Using a vaccinia virus (VV) infection model known to cause a loss in iNKT cells in a CD1d-independent, but IL-12-dependent manner, we found the virus-induced loss of iNKT cells in JNK2 KO mice was substantially lower than that observed in JNK1 KO or wild-type (WT) mice. Importantly, compared to WT mice, JNK2 KO mouse iNKT cells were found to express less surface IL-12 receptors. As with a VV infection, an IL-12 injection also resulted in a smaller decrease in JNK2 KO iNKT cells as compared to WT mice. Overall, our work strongly suggests JNK2 is a negative regulator of CD1d-mediated Ag presentation and contributes to IL-12-induced iNKT cell activation and loss during viral infections.

Original languageEnglish (US)
Pages (from-to)255-265
Number of pages11
JournalEuropean Journal of Immunology
Volume49
Issue number2
DOIs
StatePublished - Feb 1 2019

    Fingerprint

Keywords

  • Antigen processing and presentation
  • CD1d
  • NKT cells
  • Signal transduction
  • Viral infection

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this